AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

What's New in Pediatric Dermatology?

Description

In the dynamic field of pediatric dermatology, recent developments have highlighted key factors related to atopic dermatitis (AD) and its connection to food allergies. Research indicates that genetics, delivery methods, feeding practices, and early exposure to antibiotics can influence the risk of developing AD in infants. It's recommended to moisturize babies and for pregnant women to take probiotics, which may reduce AD risk by 25%. The relationship between food allergies and AD is complex; while children with AD often have food allergies, treating AD is critical to prevent these allergies. Evidence suggests that AD impacts growth due to poor sleep quality affecting growth hormone secretion, leading to concerns about growth disturbances in affected children. Additionally, elevated interleukin-4 levels in AD patients may correlate with cognitive and developmental issues, prompting the need for effective treatments like Dupilumab, which has shown promise in reducing ADHD medication needs. The prevalence of pediatric psoriasis is increasing globally, warranting more attention from healthcare professionals. Changes in gut microbiomes and climate change are believed to contribute to rising inflammatory conditions. Pediatric psoriasis is linked to various comorbidities, and treating it with systemic therapies can mitigate associated health risks. Other topics covered include the significance of early acne treatment, recognition of various skin conditions like molluscum and hemangiomas, and recommendations for management strategies. These insights reflect a comprehensive understanding of pediatric dermatological issues, underscoring the importance of early intervention and holistic family care.

View more

Conclusions

  • Early life factors such as the mode of delivery and breastfeeding impact the risk of developing atopic dermatitis (AD).
  • Moisturizing infants may decrease the risk of atopic dermatitis, while probiotics taken by pregnant women can reduce the risk of eczema in infants by 25%.
  • Food allergies are common in children with AD, but food is rarely the trigger for flare-ups, and elimination diets are not recommended as they might increase food allergy risk.
  • Eczema can lead to food allergies as aerosolized food particles can trigger abnormal immune responses through the damaged skin barrier.
  • Severe AD may contribute to growth disturbance due to poor sleep quality and reduced secretion of growth hormone, leading to higher risks for osteoporosis and fractures.
  • Elevated levels of IL-4 in the skin of children with AD are linked to cognitive impairments and increased rates of ADHD and other comorbidities.
  • Dupilumab treatment for AD is associated with a decrease in the need for ADHD medication among affected children.
  • Caregivers of children with AD report worse mental health and anxiety compared to adults with AD, highlighting the condition's broad psychosocial impact.
  • The prevalence of pediatric psoriasis is increasing, and it is often misdiagnosed, necessitating better awareness among primary care providers.
  • Increased inflammatory and autoimmune diseases in children may be linked to changes in gut microbiota and environmental factors like climate change.
  • Effective management of pediatric psoriasis can significantly reduce systemic inflammation and improve patient's overall health outcomes.
  • Gawel, Healio. (5/10). Children born by caesarean section may have increased risk for developing atopic dermatitis before age five years compared with children born by vaginal delivery.
  • Suleimani, P., & Lio, P. (2023). The State of Prevention in Atopic Dermatitis: An Update. Pediatric Allergy and Immunology. JAAD Int 2023:10:68-74.
  • Papapostolou, N., et al. (2022). Atopic dermatitis and food allergy: A complex interplay. What we know and what we would like to learn. J Clin Med. 2022 Jul; 11(14): 4232.
  • Fishbein, A., et al. (2018). Sleep disturbance in children with moderate/severe atopic dermatitis: A case control study. JAAD Vol 78 No 2 336-341.
  • Jackson-Cowan, L., et al. (2021). TH2 sensitization in the skin-gut-brain axis: How early life TH2-mediated inflammation may negatively perpetuate developmental and psychologic abnormalities. Ped Derm 2021; 38: 1032-1039.
  • Yildirim, et al. (2023). Dupilumab treatment for atopic dermatitis is associated with decreased utilization of psychostimulants for ADHD: A retrospective cohort study. JAAD April 2023.
  • Goldberg, Dermatology Advisor. (9/28). Caregivers of children with atopic dermatitis self-report worse mental health, anxiety than adult patients with AD.
  • Gross, et al. (2020). The molluscum contagiosum BOTE sign- infected or inflamed. Ped Derm Vol 37 No 3 476-479.
  • Leaute-Labreze, C., et al. (2023). Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate. Ped Derm. 2023; 40: 261-264.
  • Horsten, H-H., et al. (2016). Eczema Coxsackium Caused by Coxsackie A6. Ped Derm. Vol 33 No 3 e230-231.
  • Cohen, B. (2009). No biopsy needed for eclipse and cockade nevi found on the scalps of children. Arch Dermatol. 2009; 145(11): 1334-1336.
  • Raison-Peyron, N., & Sasseville, D. (2021). Acetophenone azine. Dermatitis 2021 Jan-Feb; 32 (1).
  • Zitelli, K., et al. (2015). Idiopathic facial aseptic granuloma: Review of an evolving clinical entity. Ped Derm 2015 July/Aug; 32(4).
  • Xia, E., et al. (2022). Isotretinoin laboratory monitoring in acne treatment: A Delphi consensus study. JAMA Derm 2022; 158(8): 942-948.